MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 30.04.2026
Pacira BioSciences P/B 2011-2026 | PCRX
P/B Jährlich Pacira BioSciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.51 | 1.59 | 2.52 | 3.8 | 4.55 | 5.03 | 5.2 | 5.19 | 6.2 | 9.94 | 22.1 | 53.3 | 9 | 3.69 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 53.3 | 1.51 | 9.55 |
P/B anderer Aktien in der Arzneimittelhersteller
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Cumberland Pharmaceuticals
CPIX
|
3.46 | $ 5.87 | 6.53 % | $ 87.2 M |  USA |
 |
Endo International plc
ENDP
|
0.0133 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.0724 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
0.88 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
0.687 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
2.78 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
0.703 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-27.6 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.8 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.0793 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
2.2 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
0.644 | $ 2.74 | 0.37 % | $ 1.05 B | Canada |
 |
Harrow Health
HROW
|
37.1 | $ 33.0 | 0.12 % | $ 1.21 B | USA |
 |
Athenex
ATNX
|
-0.473 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
9.71 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
3.01 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
0.777 | $ 2.66 | - | $ 337 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.46 | - | -39.89 % | $ 27.7 M | USA |
 |
Bausch Health Companies
BHC
|
5.38 | $ 5.47 | 0.37 % | $ 2 B | Canada |
 |
Canopy Growth Corporation
CGC
|
0.291 | $ 1.04 | -2.8 % | $ 112 M | Canada |
 |
Tilray
TLRY
|
0.358 | $ 5.29 | -3.11 % | $ 3.27 B | Canada |
 |
Solid Biosciences
SLDB
|
3.46 | $ 6.62 | 1.85 % | $ 579 M | USA |
 |
Aurora Cannabis
ACB
|
0.368 | $ 3.46 | -2.81 % | $ 190 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
0.83 | $ 1.1 | 3.77 % | $ 1.37 M | USA |
 |
Jupiter Wellness
JUPW
|
-1.09 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-1.43 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
0.492 | $ 1.12 | -0.88 % | $ 107 M | Canada |
 |
Evolus
EOLS
|
-11.7 | $ 6.09 | -5.58 % | $ 393 M | USA |
 |
Sundial Growers
SNDL
|
0.000669 | $ 1.45 | -1.36 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
0.865 | $ 8.45 | 0.96 % | $ 433 M | USA |
 |
Veru
VERU
|
4.63 | $ 2.35 | 5.86 % | $ 34.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.00923 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
0.495 | $ 0.76 | -2.32 % | $ 3.06 M | USA |
 |
Assertio Holdings
ASRT
|
0.802 | $ 23.44 | 0.3 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
2.05 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-1.56 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
0.456 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
2.85 | $ 7.04 | -2.36 % | $ 278 M | USA |
 |
Recro Pharma
REPH
|
2.27 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-2.21 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
0.769 | $ 0.73 | 3.0 % | $ 36.5 M | USA |
 |
PLx Pharma
PLXP
|
2.31 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
0.898 | $ 16.65 | 1.15 % | $ 19.4 B | USA |
 |
Zomedica Corp.
ZOM
|
0.572 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.406 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
0.914 | $ 0.79 | -2.06 % | $ 28.4 M | USA |
 |
Tricida
TCDA
|
1.87 K | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
0.121 | $ 0.76 | -0.29 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
0.857 | $ 2.12 | 0.47 % | $ 24.5 M | USA |